Cyton Biosciences Limited, UK
Karolina Bate has a bachelor's degree in Pharmacology and a PhD in Immunology from the University of Wales, Cardiff. She jointed Cyton Biosciences Ltd in 2007 and currently holds the position of Projects Director. Cyton Biosciences Ltd is a regulatory consultancy based in the UK, which is part of the global Knoell Group.
The USA and the EU are the 2 major animal health markets in the world. A combined USA/EU drug development approach allows pharmaceutical companies to co-ordinate resources, shorten development times, promote financial efficiency and ultimately expand revenue. However, a combined approach faces many challenges, as both the USA and EU have significantly different regulatory frameworks, timeframes and requirements. In such a highly regulated industry, knowledge of both USA and EU regulatory requirements, procedure, policy and standards is crucial in order to conduct joint USA/EU programs of development, prepare dossiers for submission and obtain Marketing Authorizations in both territories. This presentation will describe the similarities and differences between the USA and EU requirements forobtaining a Marketing Authorization for a Veterinary Medicinal Product.